Bandingkan Harga & Kinerja Panca Anugrah Wisesa Tbk. (MGLV) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Panca Anugrah Wisesa Tbk. dan Organon Pharma Indonesia Tbk.: Panca Anugrah Wisesa Tbk. diperdagangkan di Rp15.250 (kapitalisasi pasar 28,57 T, volume 24 jam 1,93 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Panca Anugrah Wisesa Tbk. jauh lebih besar — sekitar 273,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MGLV | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 28,57 T | 104,4 M |
Volume | 1,93 jt | — |
Lot | 19,33 rb | — |
Perputaran | 30,05 M | — |
Harga Rata-rata | 15.545,65 | — |
Nilai Transaksi | 30,05 M | — |
Harga Ekuilibrium Indikatif | 15.250 | — |
Volume Ekuilibrium Indikatif | 201 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Panca Anugrah Wisesa Tbk.
PT Panca Anugrah Wisesa Tbk (the Company) formerly PT Mitra Angrah Investama was established based on Deed of Establishment of Company No. 02 dated June 06, 2012 of Chilmiyati Rufaida, S.H., Notary in Bogor.
Selengkapnya di halaman MGLV →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
